SMR Market Research announces the release of theCord Blood Stem Cells Marketresearch report. The market is predicted to grow at a healthy pace in the coming years. Cord Blood Stem Cells Market 2021 research report presents an analysis of market size, share, and growth, trends, cost structure, statistical and comprehensive data of the global market.
This article was originally published here Onco Targets Ther. 2021 Apr 6;14:2349-2361
MIAMI--(BUSINESS WIRE)--A major scientific breakthrough in the development of novel cancer therapeutics targeting the Notch pathway has been published online ahead of print in the journal Cancer Research.
Even as the debate rages on, the International Society for Stem Cell Research (ISSCR) is expected to come up with revised guidelines for stem-cell research involving chimaeras.
The FDA approval of idecabtagene vicleucel (ide-cel; Abecma) has established a role for CAR T-cell therapy in heavily pretreated, relapsed/refractory multiple myeloma, with the product showing an unprecedented response rate and a generally favorable safety profile, said Saad Z. Usmani, MD, FACP. However, with additional BCMA-directed constructs, allogeneic CAR T-cell products, and bispecific antibodies in the pipeline, ide-cel could become just 1 of many novel options the field.
Treatment options for chronic myeloid leukemia often include targeted therapies. Treatment plans and their effectiveness may depend on the phase of the condition. Chronic myeloid leukemia (CML) is a slow-growing type of blood cancer that can affect white and red blood cells and platelets.
In response to emailed questions, Cellino Biotech CEO and Co-founder Dr. Nabiha Saklayen, talked about the formation of the company and its goal to make stem cell therapies more accessible for patients
Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021" report has been added to ResearchAndMarkets.com's offering.
When it comes to Alzheimers versus science, science is on the losing side. Alzheimers is cruel in the most insidious way.
Guelph, ON, Canada April 12, 2021 eQcell Inc. Canadas premier clinical-stage regenerative medicine company addressing conditions and diseases affecting sporting and domestic animals globally, announces the appointment to its Board of Directors of Mr.
Recent Comments